Liothyronine Sodium Tablets Recalled for Failed Impurity Specifications
Sun Pharmaceutical is recalling approximately 2,304 bottles of Liothyronine Sodium Tablets, USP, 25 mcg (lot DNC2204A) due to failed impurity and degradation specifications. The affected medication was distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a prescription medication due to failed impurity and degradation specifications. No illnesses or injuries have been reported. The hazard represents a risk-of-harm product where quality standards were not met, fitting the High severity category per the rubric.
Plain-English summary
Sun Pharmaceutical Industries Inc is recalling Liothyronine Sodium Tablets, USP, 25 mcg from lot DNC2204A (expiration date 11/2023) due to failed impurities and degradation specifications. Approximately 2,304 bottles of the medication were affected by this recall.
Liothyronine Sodium is a prescription medication used to treat thyroid conditions. The recall was initiated because the affected lot failed to meet established quality standards for impurities and degradation, meaning the medication may not perform as intended or could contain unintended substances.
The affected medication was distributed nationwide within the United States. Patients taking Liothyronine Sodium should verify the lot number (DNC2204A) and expiration date on their medication. Anyone with the affected lot should contact their healthcare provider or pharmacist for guidance before continuing use.
The recalled product
- Product
- LIOTHYRONINE SODIUM (LIOTHYRONINE SODIUM)
- Brand
- LIOTHYRONINE SODIUM
- Manufacturer
- SUN PHARMACEUTICAL INDUSTRIES INC
- Hazard
- impurity
- degradation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: DNC2204A
- Exp. Date 11/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · LIOTHYRONINE SODIUM
- ModerateLiothyronine Sodium tablets recalled due to failed impurity and degradation specifications
FDA (Drugs) · 2023-12-20
- HighLiothyronine Sodium Tablets Recalled for Failed Impurity and Degradation Specifications
FDA (Drugs) · 2023-11-08
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27